Literature DB >> 35224669

Salvaging lives in carbapenem-resistant Gram-negative osteoarticular and soft tissue infections: early compromises save lives.

Vikas M Agashe1,2, Rajeev Soman3,4, Camilla Rodrigues5, Anjali Shetty5, Ayesha Sunavala3, Sagar Raghuvanshi3,6, Aditya Menon7.   

Abstract

PURPOSE: Incidence of carbapenem-resistant Gram-negative infections has risen alarmingly all across the globe, both in developed and developing countries alike. The purpose of this study was to assess whether challenges of life-threatening infections with very high resistance pattern can be successfully addressed by a modified approach.
METHODS: This is a retrospective study of 26 patients with osteoarticular and soft tissue infections with carbapenem-resistant Gram-negative bacilli treated between 2001 and 2017 with at least two year follow-up after stopping antibiotics. All were treated by a multispecialty team approach with primary aim of "source control at the earliest and avoiding recurrence at all cost". The protocol involved opting for early compromises especially in at "risk individuals", such as resorting to early amputations, especially if salvage meant multiple bony and soft tissue reconstructive procedures, explanation of prosthesis than staged revision, avoiding internal fixations, opting for shortest possible time in external fixators with reshaping and telescoping bone ends to get bony stability and increase surface area even if it meant compromising length.
RESULTS: There were five amputations, two excision arthroplasty of hip, many minor but acceptable malunions and shortening. However, lives of 24/26 patients could be salvaged, much better than most of the published data. The two patients who died had peri-prosthetic joint infection after total hip arthroplasty and presented very late in sepsis and died within days of explantation. Infection remission could be achieved in remaining patients.
CONCLUSION: These "risk to life" cases can be successfully treated by lowering the aims and expectations from "excellent function to salvage of life and infection remission". Therein lies the "success" in these complex high-risk cases.
© 2022. The Author(s) under exclusive licence to SICOT aisbl.

Entities:  

Keywords:  Carbapenem-resistant; Carbapenemase-producing organism; Gram-negative bacilli; Multidrug-resistant bacteria; Osteomyelitis; Soft tissue infection

Mesh:

Substances:

Year:  2022        PMID: 35224669     DOI: 10.1007/s00264-022-05342-z

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  11 in total

1.  A step closer to extreme drug resistance (XDR) in gram-negative bacilli.

Authors:  David L Paterson; Yohei Doi
Journal:  Clin Infect Dis       Date:  2007-09-27       Impact factor: 9.079

2.  Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.

Authors:  Matthew E Falagas; Drosos E Karageorgopoulos
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

Review 3.  Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.

Authors:  David van Duin; Keith S Kaye; Elizabeth A Neuner; Robert A Bonomo
Journal:  Diagn Microbiol Infect Dis       Date:  2013-01-03       Impact factor: 2.803

Review 4.  The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.

Authors:  Latania K Logan; Robert A Weinstein
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

6.  Superbug--the so-called NDM-1.

Authors:  R K Srivastava; R I Ichhpujani; Shashi Khare; Arvind Rai; L S Chauhan
Journal:  Indian J Med Res       Date:  2011-05       Impact factor: 2.375

7.  Antimicrobial stewardship programme (AMSP) practices in India.

Authors:  Kamini Walia; V C Ohri; Dilip Mathai
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375

8.  Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections.

Authors:  Jorgelina de Sanctis; Lucileia Teixeira; David van Duin; Camila Odio; Geraldine Hall; J Walton Tomford; Federico Perez; Susan D Rudin; Robert A Bonomo; Wael K Barsoum; Michael Joyce; Viktor Krebs; Steven Schmitt
Journal:  Int J Infect Dis       Date:  2014-05-09       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.